MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)
source: myfinsight.com
Download
Download image
Total comprehensive
loss
-$39,189K
(-121.68%↓ Y/Y)
Net loss
-$39,182K
(-121.24%↓ Y/Y)
Foreign currency
translation adjustment
-$7K
(-121.88%↓ Y/Y)
Grant
$78K
(-88.86%↓ Y/Y)
Operating loss
-$26,499K
(-21.06%↓ Y/Y)
Total other (expense)
income, net
-$12,683K
Total revenues
$78K
(-92.91%↓ Y/Y)
Interest income
$1,026K
(-49.08%↓ Y/Y)
Gain on change in fair
value of warrant...
-$94K
(94.83%↑ Y/Y)
Total operating
expenses
$26,577K
(15.61%↑ Y/Y)
(loss) gain on change in
fair value of...
$13,800K
(4088.44%↑ Y/Y)
Other expense, net
-$3K
Research and development
$19,463K
(32.64%↑ Y/Y)
General and
administrative
$7,114K
(-14.44%↓ Y/Y)
Back